Vanguard Group
NPTN

Vanguard Group’s NEOPHOTONICS CORP NPTN Stock Holding History

Vanguard Group’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,641,795
Closed -$41.6M – 4646
2022
Q2 		$41.6M Buy
2,641,795
+51,479
+2% +$786K ﹤0.01% 2282
2022
Q1 		$39.4M Buy
2,590,316
+33,177
+1% +$505K ﹤0.01% 2420
2021
Q4 		$39.3M Sell
2,557,139
-1,055,210
-29% -$13.9M ﹤0.01% 2488
2021
Q3 		$31.5M Sell
3,612,349
-126,168
-3% -$1.15M ﹤0.01% 2620
2021
Q2 		$38.2M Sell
3,738,517
-59,483
-2% -$628K ﹤0.01% 2514
2021
Q1 		$45.4M Buy
3,798,000
+83,403
+2% +$946K ﹤0.01% 2373
2020
Q4 		$33.8M Buy
3,714,597
+198,702
+6% +$1.54M ﹤0.01% 2392
2020
Q3 		$21.4M Buy
3,515,895
+393,034
+13% +$3M ﹤0.01% 2422
2020
Q2 		$27.7M Buy
3,122,861
+817,809
+35% +$7.05M ﹤0.01% 2275
2020
Q1 		$16.7M Buy
2,305,052
+4,455
+0.2% +$33K ﹤0.01% 2374
2019
Q4 		$20.3M Buy
2,300,597
+158,856
+7% +$1.19M ﹤0.01% 2526
2019
Q3 		$13M Sell
2,141,741
-241,299
-10% -$1.36M ﹤0.01% 2690
2019
Q2 		$9.96M Buy
2,383,040
+347,176
+17% +$1.83M ﹤0.01% 2857
2019
Q1 		$12.8M Buy
2,035,864
+34,352
+2% +$241K ﹤0.01% 2694
2018
Q4 		$13M Buy
2,001,512
+166,540
+9% +$1.27M ﹤0.01% 2646
2018
Q3 		$15.2M Sell
1,834,972
-63,805
-3% -$485K ﹤0.01% 2714
2018
Q2 		$11.8M Buy
1,898,777
+186,647
+11% +$1.19M ﹤0.01% 2816
2018
Q1 		$11.7M Sell
1,712,130
-33,153
-2% -$211K ﹤0.01% 2758
2017
Q4 		$11.5M Buy
1,745,283
+228,030
+15% +$1.39M ﹤0.01% 2752
2017
Q3 		$8.44M Sell
1,517,253
-112,386
-7% -$758K ﹤0.01% 2892
2017
Q2 		$12.6M Buy
1,629,639
+114,518
+8% +$968K ﹤0.01% 2670
2017
Q1 		$13.7M Sell
1,515,121
-278,166
-16% -$2.9M ﹤0.01% 2614
2016
Q4 		$19.4M Buy
1,793,287
+25,265
+1% +$337K ﹤0.01% 2429
2016
Q3 		$28.9M Sell
1,768,022
-123,886
-7% -$1.74M ﹤0.01% 2194
2016
Q2 		$18M Buy
1,891,908
+245,463
+15% +$2.67M ﹤0.01% 2373
2016
Q1 		$23.1M Buy
1,646,445
+502,487
+44% +$5.2M ﹤0.01% 2236
2015
Q4 		$12.4M Buy
1,143,958
+108,481
+10% +$980K ﹤0.01% 2520
2015
Q3 		$7.05M Buy
1,035,477
+211,916
+26% +$1.64M ﹤0.01% 2805
2015
Q2 		$7.52M Buy
823,561
+350,746
+74% +$2.66M ﹤0.01% 2815
2015
Q1 		$3.19M Buy
472,815
+50,289
+12% +$202K ﹤0.01% 3207
2014
Q4 		$1.43M Buy
422,526
+30,700
+8% +$98.3K ﹤0.01% 3405
2014
Q3 		$1.31M Buy
391,826
+33,246
+9% +$104K ﹤0.01% 3423
2014
Q2 		$1.49M Sell
358,580
-24,313
-6% -$129K ﹤0.01% 3370
2014
Q1 		$3.04M Buy
382,893
+55,558
+17% +$414K ﹤0.01% 3047
2013
Q4 		$2.31M Buy
327,335
+1,411
+0.4% +$9.41K ﹤0.01% 3130
2013
Q3 		$2.41M Buy
325,924
+5,502
+2% +$42.8K ﹤0.01% 3064
2013
Q2 		$2.78M Buy
+320,422
New +$2.06M ﹤0.01% 2948

Other funds holding NPTN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Vanguard Group's NPTN Position: Q3 2022 in Review

Vanguard Group sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 2,641,795 shares — an estimated $41.6M sold.

Vanguard Group first reported a position in NPTN in Q2 2013 and held it in 37 quarters. The position peaked at $45.4M in Q1 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.

  • Vanguard Group reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
  • Vanguard Group sold 2,641,795 NEOPHOTONICS CORP shares in Q3 2022, an estimated $41.6M.
  • Vanguard Group first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 37 quarters.
  • Vanguard Group's NEOPHOTONICS CORP position peaked at $45.4M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.

Based on Vanguard Group's 13F filing for Q3 2022, filed 14 Nov 2022.